Stay updated on Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added Prostate cancer as a related topic and a MedlinePlus Genetics link.
    Difference
    0.2%
    Check dated 2026-04-02T00:39:09.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T15:45:19.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Added page revision note: Revision: v3.4.3. Removed Prostate cancer-related topics including MedlinePlus Genetics (Revision: v3.4.2).
    Difference
    0.2%
    Check dated 2026-03-11T14:35:27.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Added 'Prostate cancer' as a topic and included a link to the MedlinePlus Genetics resource under related topics.
    Difference
    0.2%
    Check dated 2026-03-04T10:01:19.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Removed the Prostate cancer topic and the MedlinePlus Genetics related topic from the page.
    Difference
    0.2%
    Check dated 2026-02-25T08:43:40.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    Added related topics sections for Prostate cancer and MedlinePlus Genetics, serving as navigation/context rather than core study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-18T04:24:05.000Z thumbnail image

Stay in the know with updates to Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial page.